22
May
May
Cannabidiol is going mainstream with two CBD drugs getting the green light from the FDA. Epidiolex, is a 98% pure, botanical origin CBD drug proving effective for treatment of epilepsy. Specifically, the Dravet and Lennox-Gastaut syndrome versions. This is not the first time the FDA has given permissions to a CBD drug. Back in 2015, […]